Sol-Gel Revenue and Competitors
Estimated Revenue & Valuation
- Sol-Gel's estimated annual revenue is currently $12.7M per year.
- Sol-Gel's estimated revenue per employee is $201,000
Employee Data
- Sol-Gel has 63 Employees.
- Sol-Gel grew their employee count by -2% last year.
Sol-Gel's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head HR | Reveal Email/Phone |
2 | Operations Manager | Reveal Email/Phone |
3 | RA manager | Reveal Email/Phone |
4 | Purchasing Manager | Reveal Email/Phone |
5 | Senior Researcher | Reveal Email/Phone |
6 | Senior Analytical Chemist | Reveal Email/Phone |
Sol-Gel Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Sol-Gel?
Sol-Gel Technologies (NASDAQ: SLGL) is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Our current product candidate pipeline consists of late-stage branded product candidates that leverage our proprietary silica-based microencapsulation technology platform, and several generic product candidates across multiple indications. Our unique technology platform was designed to enable drug substances to be entrapped in porous silica microcapsules in order to address the limitations of topical drug delivery by stabilizing active drug ingredients, extending drug delivery time and reducing potential irritation caused by direct application to the skin. For more information, please visit www.Sol-Gel.com
keywords:N/A
N/A
Total Funding
63
Number of Employees
$12.7M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sol-Gel News
Sol-Gel Technologies' work to expand the treatment options for patients with the skin condition rosacea has paid off, with the FDA approving...
Sol-Gel is a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the...
Sol-Gel is a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the...
Other Companies in Ness Ziona
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.5M | 71 | 3% | $25.2M |
#2 | $11.2M | 73 | 12% | N/A |
#3 | $19.1M | 78 | 5% | N/A |
#4 | $25.7M | 78 | -7% | N/A |
#5 | $33.7M | 102 | 2% | N/A |